Cochlear Limited (COH.AX)
- Previous Close
322.90 - Open
324.50 - Bid 318.28 x 10000
- Ask 326.00 x 3400
- Day's Range
319.78 - 325.96 - 52 Week Range
220.40 - 350.17 - Volume
86,884 - Avg. Volume
145,174 - Market Cap (intraday)
20.957B - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
60.26 - EPS (TTM)
5.31 - Earnings Date Feb 18, 2024
- Forward Dividend & Yield 4.00 (1.25%)
- Ex-Dividend Date Mar 21, 2024
- 1y Target Est
283.57
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
www.cochlear.comRecent News: COH.AX
Performance Overview: COH.AX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COH.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COH.AX
Valuation Measures
Market Cap
20.96B
Enterprise Value
20.68B
Trailing P/E
60.14
Forward P/E
46.30
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.81
Price/Book (mrq)
11.76
Enterprise Value/Revenue
9.62
Enterprise Value/EBITDA
36.63
Financial Highlights
Profitability and Income Statement
Profit Margin
16.30%
Return on Assets (ttm)
11.80%
Return on Equity (ttm)
20.04%
Revenue (ttm)
2.15B
Net Income Avi to Common (ttm)
350.4M
Diluted EPS (ttm)
5.31
Balance Sheet and Cash Flow
Total Cash (mrq)
485.2M
Total Debt/Equity (mrq)
11.60%
Levered Free Cash Flow (ttm)
272.19M
Research Analysis: COH.AX
Company Insights: COH.AX
COH.AX does not have Company Insights